Truveris

Truveris provides software solutions designed to drive transparency, accessibility, and affordability in the pharmacy benefits sector by offering tools and services that help employers, health plans, and unions manage and optimize their pharmacy benefit programs. Truveris' platform offers data analytics and pricing algorithms to analyze drug prices and claim data, aiming to reduce costs and improve outcomes for plan sponsors and their members. This includes monitoring market trends, benchmarking plan performance, and providing insights on pharmacy spend.

Additionally, Truveris engages in patient advocacy by assisting individuals in understanding their pharmacy benefits and exploring cost-saving opportunities for their prescriptions.

Key customers and partnerships

Truveris serves a diverse customer base that includes health insurers, self-insured corporations, unions, and government entities at various levels. As of May 2023, the company supported over 7 million members and patients, analyzing more than 50 million pharmacy claims annually and managing USD 8.4 billion in annual drug spend.

In September 2023, Truveris partnered with the Benefit Advisors Network (BAN) to offer BAN members access to Truveris’ platform.

Funding and financials

In May 2024, the company raised USD 15 million in a Series E funding round co-led by Canaan Partners and New Leaf Venture Partners. The funds raised were set aside to accelerate the next phase of the company's development and expand its operations across US employers.